Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Citi
Moodys
Colorcon
Teva
Harvard Business School
Johnson and Johnson
McKesson
Queensland Health

Generated: January 22, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Sipuleucel-T

« Back to Dashboard

US Patents for Sipuleucel-T

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sipuleucel-T ➤ Sign Up Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereof The Trustees of the University of Pennsylvania (Philadelphia, PA) ➤ Sign Up
Sipuleucel-T ➤ Sign Up Tricyclic lactones for treatment of cancer Glactone Pharma Development AB (Helsingborg, SE) ➤ Sign Up
Sipuleucel-T ➤ Sign Up Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereof The Trustees of the University of Pennsylvania (Philadelphia, PA) ➤ Sign Up
Sipuleucel-T ➤ Sign Up Substituted 2,3-dihydroimidazo[1,2-C]quinazoline salts Bayer Intellectual Property GmbH (Monheim, DE) ➤ Sign Up
Sipuleucel-T ➤ Sign Up Vitamin D analogues of pharmaceutical interest UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (Santiago de Compostela, ES) UNIVERSIDADE DA CORUNA (A Coruna, ES) SERVIZO GALEGO DE SAUDE (SERGAS) (Santiago de Compostela, ES) ➤ Sign Up
Sipuleucel-T ➤ Sign Up Cannabinoid receptor modulators Arena Pharmaceuticals, Inc. (San Diego, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Sipuleucel-T

Drugname Country Document Number Estimated Expiration Related US Patent
Sipuleucel-T World Intellectual Property Organization (WIPO) 2012142208 2031-04-13 ➤ Sign Up
Sipuleucel-T China 103097368 2030-07-19 ➤ Sign Up
Sipuleucel-T European Patent Office 2595972 2030-07-19 ➤ Sign Up
Sipuleucel-T Spain 2553248 2030-07-19 ➤ Sign Up
Sipuleucel-T Japan 2013531051 2030-07-19 ➤ Sign Up
Sipuleucel-T Japan 5855098 2030-07-19 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Argus Health
Accenture
QuintilesIMS
Teva
Johnson and Johnson
Colorcon
Cerilliant
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.